Sushil Patel
Chief Executive Officer chez REPLIMUNE GROUP, INC.
Fortune : 2 M $ au 31/03/2024
Postes actifs de Sushil Patel
Sociétés | Poste | Début | Fin |
---|---|---|---|
REPLIMUNE GROUP, INC. | Director/Board Member | 01/04/2024 | - |
Chief Executive Officer | 01/04/2024 | - | |
Public Communications Contact | 03/05/2021 | 03/01/2023 | |
Corporate Officer/Principal | 03/01/2023 | 01/04/2024 | |
REVOLUTION MEDICINES, INC. | Director/Board Member | 16/06/2022 | - |
Independent Dir/Board Member | 16/06/2022 | - |
Historique de carrière de Sushil Patel
Anciens postes connus de Sushil Patel
Sociétés | Poste | Début | Fin |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/04/2008 | 01/05/2021 |
Formation de Sushil Patel
Imperial College London | Graduate Degree |
University of London | Doctorate Degree |
University of Warwick | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Royaume-Uni | 4 |
Opérationnelle
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
REVOLUTION MEDICINES, INC. | Health Technology |
REPLIMUNE GROUP, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Sushil Patel
- Expérience